Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women

Abstract

Background/Objectives:

Body mass index (BMI), waist circumference (WC), body weight modification, and rate of weight increase over 10 years were evaluated in relation to high-sensitive C-reactive protein (hs-CRP) to assess the association of cross-sectional or longitudinal estimates of obesity/overweight with levels of circulating CRP, a well established and standardized marker of low-grade inflammation, in relation to cardiovascular risk.

Subjects:

This study included a subgroup of 390 menopausal women participating in a large currently ongoing epidemiological study (Progetto Atena; N=5062).

Results:

At the final visit, women in the third tertile of BMI, compared with those in the first tertile, showed the following odds ratio (OR) of having high hs-CRP values: III vs I tertile OR, 3.55; 95% confidence interval, 1.94–6.49, P<0.001, adjusted for age, and metabolic syndrome. Similar results were obtained when we evaluated women in the third tertile of WC, or those in the highest group of estimated weight increase, relative to their weight at age 20 years or in the group of highest rate of weight increase over 10 years of observation (weight at the final visit−weight at the baseline visit divided by time in months between visits).

Conclusions:

The independent relations between different markers of overweight/obesity and elevated hs-CRP consistently indicate that high (above 1.5 mg l–1, median) hs-CRP is a major biochemical counterpart of cross-sectional or longitudinal estimates of increased adipose tissue mass.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Barbagallo CM, Cavera G, Sapienza M, Noto D, Cefalù AB, Pagano M et al. (2001). Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: the Ventimiglia di Sicilia project. Int J Obes Relat Metab Disord 25, 185–190.

    Article  CAS  Google Scholar 

  • Beer-Borst S, Morabia A, Hercberg S, Vitek O, Bernstein MS, Galan P et al. (2000). Obesity and other health determinants across Europe: the EURALIM project. J Epidemiol Community Health 54, 424–430.

    Article  CAS  Google Scholar 

  • Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC (1990). Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12, 1179–1186.

    Article  CAS  Google Scholar 

  • Devaraj S, Singh U, Jialal I (2009). Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 20, 182–189.

    Article  CAS  Google Scholar 

  • Fried SK, Bunkin DA, Greenberg AS (1998). Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83, 847–850.

    CAS  PubMed  Google Scholar 

  • Fry J, Finley W (2005). The prevalence and costs of obesity in the EU. Proc Nutr Soc 64, 359–362.

    Article  Google Scholar 

  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735–2752.

    Article  Google Scholar 

  • Haffner SM (2006). Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity 14, 121–127.

    Article  Google Scholar 

  • Haffner SM (2007). Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 120, S10–S17.

    Article  CAS  Google Scholar 

  • Hamer M, Steptoe A (2009). Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women. Am J Clin Nutr 89, 85–89.

    Article  CAS  Google Scholar 

  • Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280, E745–E751.

    Article  CAS  Google Scholar 

  • Klipstein-Grobusch K, Georg T, Boeing H (1997). Interviewer variability in anthropometric measurements and estimates of body composition. Int J Epidemiol 26, S174–S180.

    Article  Google Scholar 

  • Koh KK, Han SH, Quon MJ (2005). Inflammatory markers and the metabolic syndrome. Insights from therapeutic interventions. J Am Coll Cardiol 46, 1978–1985.

    Article  CAS  Google Scholar 

  • Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977). Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 3, 882–884.

    Google Scholar 

  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.

    Article  CAS  Google Scholar 

  • Mohamed-Ali V, Pinkney JH, Coppack SW (1998). Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22, 1145–1158.

    Article  CAS  Google Scholar 

  • Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T et al. (2004). Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 89, 2728–2735.

    Article  CAS  Google Scholar 

  • Oda E (2008). The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31, 1283–1291.

    Article  CAS  Google Scholar 

  • Okita K, Nishijima H, Murakami T, Nagai T, Morita N, Yonezawa K et al. (2004). Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 24, 868–873.

    Article  Google Scholar 

  • Panico S, Dello Iacovo R, Celentano E, Galasso R, Muti P, Salvatore M et al. (1992). Progetto Atena, a study on the etiology of major chronic diseases in women: design, rationale and objectives. Eur J Epidemiol 8, 601–608.

    Article  CAS  Google Scholar 

  • Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP (1998). The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128, 127–137.

    Article  CAS  Google Scholar 

  • Pérez Pérez A, Ybarra Muñoz J, Blay Cortés V, de Pablos Velasco P (2007). Obesity and cardiovascular disease. Public Health Nutr 10, 1156–1163.

    Article  Google Scholar 

  • Ridker PM (2007). Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 65, S253–S259.

    Article  Google Scholar 

  • Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS et al. (2007). Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol 100, 1659–1664.

    Article  Google Scholar 

  • Rosengren A, Wedel H, Wilhelmsen L (1999). Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 20, 269–277.

    Article  CAS  Google Scholar 

  • Scherer PE (2006). Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537–1545.

    Article  CAS  Google Scholar 

  • Selvin E, Paynter NP, Erlinger TP (2007). The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167, 31–39.

    Article  CAS  Google Scholar 

  • Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW (1981). Improved reagent for enzymatic determination of serum cholesterol. J Clin Chem Biochem 19, 838–839.

    Google Scholar 

  • Wahlefeld AW (1974). Triglyceride determination after enzymatic hydrolysis, Bergmeyer HU (ed). Methods of Enzymatic Analysis. Academic Press: New York. vol. 4, 2nd edn 1831.

    Google Scholar 

  • Walker M, Wannamethee G, Whincup PH, Shaper AG (1995). Weight change and risk of heart attack in middle-aged British men. Int J Epidemiol 24, 694–703.

    Article  CAS  Google Scholar 

  • Wannamethee SG, Shaper AG (1999). Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22, 1266–1272.

    Article  CAS  Google Scholar 

  • Wannamethee SG, Shaper AG, Walker M (2005). Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health 59, 134–139.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by funds from MIUR 2001 no. 068937 and 2004 no. 065985.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Gentile.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gentile, M., Panico, S., Rubba, F. et al. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women. Eur J Clin Nutr 64, 873–878 (2010). https://doi.org/10.1038/ejcn.2010.69

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2010.69

Keywords

This article is cited by

Search

Quick links